The Toll-like receptor 5 agonist entolimod suppresses hepatic metastases in a murine model of ocular melanoma via an NK cell-dependent mechanism-Reference-Cited by-同舟云学术

The Toll-like receptor 5 agonist entolimod suppresses hepatic metastases in a murine model of ocular melanoma via an NK cell-dependent mechanism

Published:2015-12-08 Issue:3 Volume:7 Page:2936-2950
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Yang Hua¹,Brackett Craig M.²,Morales-Tirado Vanessa Marie³,Li Zezhong¹,Zhang Qing¹,Wilson Matthew W.³,Benjamin Camille²,Harris Wayne⁴,Waller Edmund K.⁴,Gudkov Andrei V.²⁵,Burdelya Lyudmila G.²,Grossniklaus Hans E.¹

Affiliation:

1. Department of Ophthalmology, Emory University, Atlanta, GA, USA

2. Department of Cell Stress Biology, Roswell Park Cancer Institute, Buffalo, NY, USA

3. Department of Ophthalmology, Hamilton Eye Institute, The University of Tennessee Health Science Center, Memphis, TN, USA

4. Deparment of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA

5. Cleveland BioLabs, Inc., Buffalo, NY, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing innate immune pathways for therapeutic advancement in cancer;Signal Transduction and Targeted Therapy;2024-03-25

2. Dysfunctional TLR1 reduces the therapeutic efficacy of chemotherapy by attenuating HMGB1-mediated antitumor immunity in locally advanced colorectal cancer;Scientific Reports;2023-11-09

3. The inducible secreting TLR5 agonist, CBLB502, enhances the anti-tumor activity of CAR133-NK92 cells in colorectal cancer;Cancer Biology & Medicine;2023-09-19

4. TLR5 agonists enhance anti-tumor immunity and overcome resistance to immune checkpoint therapy;Communications Biology;2023-01-12

5. Fibronectin Functions as a Selective Agonist for Distinct Toll-like Receptors in Triple-Negative Breast Cancer;Cells;2022-06-30